1. Home
  2. FGEN vs KSCP Comparison

FGEN vs KSCP Comparison

Compare FGEN & KSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • KSCP
  • Stock Information
  • Founded
  • FGEN 1993
  • KSCP 2013
  • Country
  • FGEN United States
  • KSCP United States
  • Employees
  • FGEN N/A
  • KSCP N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • KSCP Telecommunications Equipment
  • Sector
  • FGEN Health Care
  • KSCP Telecommunications
  • Exchange
  • FGEN Nasdaq
  • KSCP Nasdaq
  • Market Cap
  • FGEN 33.5M
  • KSCP 35.9M
  • IPO Year
  • FGEN 2014
  • KSCP 2022
  • Fundamental
  • Price
  • FGEN $7.44
  • KSCP $7.68
  • Analyst Decision
  • FGEN Strong Buy
  • KSCP Strong Buy
  • Analyst Count
  • FGEN 1
  • KSCP 3
  • Target Price
  • FGEN $250.00
  • KSCP $15.67
  • AVG Volume (30 Days)
  • FGEN 66.4K
  • KSCP 451.0K
  • Earning Date
  • FGEN 08-05-2025
  • KSCP 08-13-2025
  • Dividend Yield
  • FGEN N/A
  • KSCP N/A
  • EPS Growth
  • FGEN N/A
  • KSCP N/A
  • EPS
  • FGEN N/A
  • KSCP N/A
  • Revenue
  • FGEN $6,996,000.00
  • KSCP $11,468,000.00
  • Revenue This Year
  • FGEN N/A
  • KSCP $16.17
  • Revenue Next Year
  • FGEN N/A
  • KSCP $39.02
  • P/E Ratio
  • FGEN N/A
  • KSCP N/A
  • Revenue Growth
  • FGEN N/A
  • KSCP N/A
  • 52 Week Low
  • FGEN $4.50
  • KSCP $2.45
  • 52 Week High
  • FGEN $38.25
  • KSCP $28.57
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 64.36
  • KSCP 74.90
  • Support Level
  • FGEN $7.03
  • KSCP $6.88
  • Resistance Level
  • FGEN $5.73
  • KSCP $8.31
  • Average True Range (ATR)
  • FGEN 0.50
  • KSCP 0.56
  • MACD
  • FGEN 0.35
  • KSCP 0.31
  • Stochastic Oscillator
  • FGEN 100.00
  • KSCP 96.18

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

Share on Social Networks: